PRECIGEN, INC.

Nasdaq:PGEN

Pharmaceutical Preparations·GERMANTOWN, MD

Precigen, Inc. is an American biotechnology company.

CFO

Thomasian Harry Jr.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K/A	FY 2024	12/31/24	4/28/25	→
10-K	FY 2024	12/31/24	3/19/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

31 shown

Filed	Period
11/13/25	Q4 FY2025	→
5/14/25	Q2 FY2025	→
3/19/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
8/6/24	Q3 FY2024	→
↓

News (8-K)

49 shown

Filed	Type	Description
9/17/25	Other	Unregistered Sales of Equity Securities	→
9/3/25	Agreement	Entry into a Material Definitive Agreement	→
8/18/25	Agreement	Entry into a Material Definitive Agreement	→
8/18/25	Reg FD	Regulation FD Disclosure	→
6/30/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/16/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/19/25	S-3	S-3	→
5/16/25	ARS	ARS	→
8/8/24	424B5	424B5	→
8/6/24	424B5	424B5	→
5/28/24	ARS	ARS	→
12/29/23	S-3	S-3	→
↓

Filing History(1003 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 13, 2026

0001854794-26-000001

—

8.6 KB

SCHEDULE 13G

Jan 23, 2026

0000902664-26-000427

—

17.4 KB

Dec 22, 2025

0001213900-25-124794PRIMARY DOCUMENT

Dec 22, 2025

26.3 KB

144

Dec 22, 2025

0001968582-25-001280

—

9.7 KB

Dec 16, 2025

0000950103-25-016198FORM 4

Dec 12, 2025

5.3 KB

144

Dec 12, 2025

0001958244-25-004536

—

9.4 KB

SCHEDULE 13D/A

Nov 21, 2025

0001213900-25-113780

—

19.1 KB

Nov 21, 2025

0001213900-25-113771PRIMARY DOCUMENT

Nov 19, 2025

20.7 KB

144

Nov 20, 2025

0001949846-25-000621

—

7.1 KB

144/A

Nov 20, 2025

0001949846-25-000620

—

6.6 KB

144

Nov 19, 2025

0001949846-25-000615

—

6.4 KB

10-Q

Nov 13, 2025

0001356090-25-00003410-Q

Sep 30, 2025

7.8 MB

8-K

Nov 13, 2025

0000950103-25-014683FORM 8-K

Nov 13, 2025

299.1 KB

SCHEDULE 13G/A

Oct 30, 2025

0001085146-25-005965

—

8.6 KB

Oct 1, 2025

0000950103-25-012666FORM 4

Sep 29, 2025

7.2 KB

Sep 30, 2025

0001213900-25-094114PRIMARY DOCUMENT

Sep 30, 2025

16.9 KB

144

Sep 30, 2025

0001949846-25-000510

—

8.0 KB

144

Sep 30, 2025

0001958244-25-004358

—

5.9 KB

Sep 30, 2025

0000950103-25-012560FORM 4

Sep 26, 2025

4.5 KB

Sep 30, 2025

0000950103-25-012557FORM 4

Sep 29, 2025

4.5 KB

144

Sep 29, 2025

0001958244-25-004357

—

7.2 KB

Sep 26, 2025

0000950103-25-012312FORM 4

Sep 25, 2025

6.6 KB

SCHEDULE 13G

Sep 23, 2025

0002071876-25-000050

—

7.4 KB

EFFECT

Sep 19, 2025

9999999995-25-003021

—

1.8 KB

SCHEDULE 13D/A

Sep 19, 2025

0001213900-25-089729

—

23.3 KB

25 filings shown

Filed	Form	Description
5/16/25	DEFA14A	DEFA 14A	→
5/16/25	DEF 14A	DEF 14A	→
5/6/25	PRE 14A	PRE 14A	→
5/28/24	DEF 14A	DEF 14A	→
4/25/23	DEFA14A	FORM DEFA14A	→
4/25/23	DEF 14A	FORM-DEF14A	→
↓

PRECIGEN, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1003 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/22/25	4	PRIMARY DOCUMENT	→
12/16/25	4	4	→
11/21/25	4	PRIMARY DOCUMENT	→
10/1/25	4	4	→
9/30/25	4	PRIMARY DOCUMENT	→
9/30/25	4	4	→
↓

Filed	Form	Description
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/23/26	SCHEDULE 13G	SCHEDULE 13G	→
12/22/25	144	144	→
12/12/25	144	144	→
11/21/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
11/20/25	144	144	→
↓